Hydrophilic Catheters Market Size, Share and Growth Outlook, 2026

Hydrophilic Catheters Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Hydrophilic Catheters Market size is forecast to increase from $2.02 Billion in 2026 to $3.42 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.

The Hydrophilic Catheters market report provides detailed analysis and outlook of Hydrophilic Catheters segments including By Product Type (Hydrophilic Intermittent Catheters, Hydrophilic Foley, Hydrophilic External ), By Design & Configuration (Pre-lubricated, Standard Hydrophilic Catheters, Closed-System Hydrophilic Catheters ), By Material Composition (Silicone-Based Hydrophilic Catheters, Polyurethane, Polyvinyl Chloride, Latex-Based Hydrophilic Catheters), By Application (Urinary Incontinence & Retention, Neurogenic Bladder & Spinal Cord Injuries, Benign Prostatic Hyperplasia, Post-operative Urinary Management), By End-User & Care Setting (Hospitals & Long-Term Acute Care Units, Home Healthcare Settings & Self-Catheterization Users, Specialty Urology Clinics & Rehabilitation Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Hydrophilic Catheters Industry Overview

Innovation and Patient-Centered Design Drive Hydrophilic Catheter Adoption

The hydrophilic catheters industry continues to expand as healthcare providers prioritize patient comfort, infection prevention, and ease of use in urological and interventional procedures. Hydrophilic coatings reduce surface friction when activated by water, enabling smoother insertion and removal while minimizing urethral trauma and patient discomfort. These characteristics have made hydrophilic catheters increasingly important across intermittent catheterization, neurogenic bladder management, and minimally invasive vascular interventions. Ongoing product innovation, regulatory updates, and technological advancements are strengthening the role of hydrophilic catheter systems within modern healthcare practice.

Updated Coding Frameworks Support Market Standardization

Healthcare reimbursement and coding reforms are playing an increasingly important role in shaping the hydrophilic catheters industry. New Healthcare Common Procedure Coding System codes for hydrophilic intermittent urinary catheters have been implemented to improve consistency in product classification, reimbursement processes, and patient access. Throughout the transition period, the Pricing, Data Analysis, and Coding contractor collaborated with manufacturers and distributors to facilitate adoption of the updated coding structure. These efforts help ensure that healthcare providers can accurately document product utilization while maintaining access to catheter technologies that meet specific clinical requirements. Standardized coding frameworks support greater transparency and efficiency across the healthcare supply chain.

Infection Prevention Remains a Key Product Development Focus

Manufacturers continue to introduce catheter technologies designed to reduce contamination risks and improve user experience. HR HealthCare launched the EZ-Protect® Hydrophilic Closed System Intermittent Catheter line, incorporating a user-activated water pouch that hydrates the catheter coating immediately before use. The design promotes a smooth and touchless catheterization process, helping minimize direct handling and supporting infection prevention objectives. Such innovations reflect the industry's ongoing emphasis on patient safety, convenience, and self-care capabilities. As more patients perform intermittent catheterization in home settings, demand continues to grow for systems that simplify procedures while maintaining high standards of hygiene and comfort.

Hydrophilic Coatings Expand Beyond Urological Applications

The benefits of hydrophilic coating technologies are increasingly being applied to specialized interventional medical devices. Johnson & Johnson MedTech introduced the CEREGLIDE™ 42 and 57 aspiration catheters for ischemic stroke treatment, incorporating proprietary hydrophilic coatings to reduce friction during navigation through complex vascular anatomy. These devices are designed to improve physician access to distal blood clots and support more consistent clot retrieval procedures. The application of hydrophilic technologies in neurovascular interventions demonstrates the versatility of advanced coating systems and highlights opportunities for innovation beyond traditional urinary catheter markets. As minimally invasive procedures continue to expand, hydrophilic surface technologies are becoming increasingly valuable across a broad range of medical device applications.

Hydrophilic Catheters Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Hydrophilic Catheters market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Coloplast A/S, Wellspect HealthCare (Dentsply Sirona Inc.), Hollister Incorporated, Convatec Group PLC, Teleflex Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Medtronic plc, Cook Medical LLC. The Hydrophilic Catheters market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Hydrophilic Catheters industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Hydrophilic Catheters Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Hydrophilic Catheters companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Hydrophilic Catheters markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Hydrophilic Catheters Market Competitive Benchmarking and Company Analysis

Leading companies in Hydrophilic Catheters industry include- Coloplast A/S, Wellspect HealthCare (Dentsply Sirona Inc.), Hollister Incorporated, Convatec Group PLC, Teleflex Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Becton, Dickinson and Company (BD), Medtronic plc, Cook Medical LLC. The Hydrophilic Catheters market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Hydrophilic Catheters Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Hydrophilic Catheters market remains one of the strongest-performing segments in the country.
The US Hydrophilic Catheters Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Hydrophilic Catheters market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Hydrophilic Catheters industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Hydrophilic Catheters markets

Canada's strong Hydrophilic Catheters sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Hydrophilic Catheters market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Hydrophilic Catheters Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Hydrophilic Catheters market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Hydrophilic Catheters population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Hydrophilic Catheters industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Hydrophilic Catheters market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Hydrophilic Catheters sales through 2034

France Hydrophilic Catheters companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Hydrophilic Catheters Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Hydrophilic Catheters distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Hydrophilic Catheters Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Hydrophilic Catheters market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Hydrophilic Catheters industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Hydrophilic Catheters industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Hydrophilic Catheters Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Hydrophilic Catheters market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Hydrophilic Catheters market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Hydrophilic Catheters Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Hydrophilic Catheters Market Segmentation

By Product Type
Hydrophilic Intermittent Catheters
Hydrophilic Foley
Hydrophilic External
By Design & Configuration
Pre-lubricated
Standard Hydrophilic Catheters
Closed-System Hydrophilic Catheters
By Material Composition
Silicone-Based Hydrophilic Catheters
Polyurethane
Polyvinyl Chloride
Latex-Based Hydrophilic Catheters
By Application
Urinary Incontinence & Retention
Neurogenic Bladder & Spinal Cord Injuries
Benign Prostatic Hyperplasia
Post-operative Urinary Management
By End-User & Care Setting
Hospitals & Long-Term Acute Care Units
Home Healthcare Settings & Self-Catheterization Users
Specialty Urology Clinics & Rehabilitation Centers

Top Companies in Hydrophilic Catheters Industry

Coloplast A/S
Wellspect HealthCare (Dentsply Sirona Inc.)
Hollister Incorporated
Convatec Group PLC
Teleflex Incorporated
B. Braun Melsungen AG
Boston Scientific Corporation
Becton, Dickinson and Company (BD)
Medtronic plc
Cook Medical LLC

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025